LTA and neoplasm: Ectopic delivery of LTα/β or LIGHT (aka TNFSF-14 or CD258) promotes PNAd+ HEV, CCL19/CCL21 production, massive naïve T cell infiltration, and (tumor-specific) cross-priming in the context of TLO structures (9, 18, 36, 46–49).